Skip to content

Vincenzo Micale

3 papers in the library · 49 citations · publishing 2017-2023

Papers

Sort Most recent Most cited

The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

International Journal of Molecular Sciences February 15, 2023 Martina di Bartolomeo, Tibor Stark, Serena di Martino et al. 23 citations

Adolescent exposure to cannabinoids as a postnatal environmental insult may increase the risk of psychosis in subjects exposed to perinatal insult, as suggested by the two-hit hypothesis of schizophrenia. Here, we hypothesized that peripubertal Δ9-tetrahydrocannabinol (aTHC) may affect the impact of prenatal methylazoxymethanol acetate (MAM) or perinatal THC (pTHC) exposure in adult rats. We...

Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment.

Pharmacological Research December 1, 2021 Tibor Stark, Serena di Martino, Filippo Drago et al.

The recent shift in socio-political debates and growing liberalization of Cannabis use across the globe has raised concern regarding its impact on vulnerable populations such as adolescents. Concurrent with declining perception of Cannabis harms, more adolescents are using it daily in several countries and consuming marijuana strains with high content of psychotropic delta...

Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia

Neurotoxicity Research July 1, 2017 Jana Ruda-Kucerova, Zuzana Babinska, Tibor Stark et al. 26 citations

Ketamine may prove to be a potential candidate in treating the widespread drug addiction/substance abuse epidemic among patients with schizophrenia. Clinical studies have shown ketamine to reduce cocaine and heroin cravings. However, the use of ketamine remains controversial as it may exacerbate the symptoms of schizophrenia. Therefore, the aim of this study is to characterize the effects of...